Extracted from this filing and checked against the source text.
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.82
SPRUCE BIOSCIENCES, INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5450(a)(1), 5815(a)(1)(B)(ii)(d), 5810(c)(3)(A)(ii), 5800).
- Exchange
- nasdaq
- Notice
- delisting notice
- Deficiency
- minimum bid price
- Rules
- 5450(a)(1), 5815(a)(1)(B)(ii)(d), 5810(c)(3)(A)(ii), 5800
Exact text from the filing
pects that Nasdaq will file a Form 25-NSE with the Securities and Exchange Commission, which will remove the Company’s securities from listing and registration on Nasdaq. The Company has appealed Nasdaq’s determination to its Hearings Panel pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series. However, pursuant to Nasdaq Listing Rule 5815(a)(1)(B)(ii)(d), a timely request for a hearing will not stay the trading suspension of the Company’s common stock as the Company was afforded the second 180 days compliance period described in Nasdaq Listing Rule 5810(c)(3)(A)(ii) and
View on SEC.gov
Restructurings & Charges
SEC 8-K Item 2.05/2.06
confidence 0.9
SPRUCE BIOSCIENCES, INC. announced a restructuring with charges of approximately $0.9 million (workforce reduction of 55%).
- Type
- restructuring
- Charge
- approximately $0.9 million
- Headcount
- workforce reduction of 55%
Exact text from the filing
and expenditures relating to the workforce reduction will not be known until all related activities have been completed. The Company estimates that it will incur approximately $0.9 million in cash charges in connection with the workforce reduction, consisting of expenses related to severance payments and healthcare coverage assistance and related costs. The Company
View on SEC.gov